Efficacy and safety of tigecycline versus levofloxacin for community-acquired pneumonia

BACKGROUND: Tigecycline, an expanded broad-spectrum glycylcycline, exhibits in vitro activity against many common pathogens associated with community-acquired pneumonia (CAP), as well as penetration into lung tissues that suggests effectiveness in hospitalized CAP patients. The aim of the present st...

Descripción completa

Detalles Bibliográficos
Autores principales: Tanaseanu, Cristina, Milutinovic, Slobodan, Calistru, Petre I, Strausz, Janos, Zolubas, Marius, Chernyak, Valeriy, Dartois, Nathalie, Castaing, Nathalie, Gandjini, Hassan, Cooper, C Angel
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2009
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2753558/
https://www.ncbi.nlm.nih.gov/pubmed/19740418
http://dx.doi.org/10.1186/1471-2466-9-44

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2753558/
https://www.ncbi.nlm.nih.gov/pubmed/19740418
http://dx.doi.org/10.1186/1471-2466-9-44

Ejemplares similares